Back to TCRX
BAKER BROS. ADVISORS LP → TCRX
BAKER BROS. ADVISORS LP TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$876K
Q3 2026
Peak value
$2.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.8M |
| Q1 2026 | $2.8M |
| Q2 2026 | $2.7M |
| Q3 2026 | $876K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $876K | 2.78M | — | — |
| Q2 2026 | $2.7M | 2.78M | — | — |
| Q1 2026 | $2.8M | 2.78M | — | — |
| Q4 2025 | $2.8M | 2.78M | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M